News >

Concomitant Chemoradiation Remains Standard in Locally Advanced Cervical Cancer

Jason Harris
Published: Monday, Feb 19, 2018

Sudeep Gupta, MD

Sudeep Gupta, MD
Standard cisplatin-based concomitant chemoradiation induced superior disease-free survival (DFS) compared with neoadjuvant chemotherapy followed by radical surgery in women with locally advanced squamous cervical cancer, according to findings from a phase III trial published online in the Journal of Clinical Oncology.

<.001).
Gupta S, Maheshwari Am, Parab P, et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial [published online February 12, 2018]. J Clin Oncol. doi: 10.1200/JCO.2017.75.9985.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
x